Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05932199 |
| Title | Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Baylor College of Medicine |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Duke Cancer Institute | NOT_YET_RECRUITING | Durham | North Carolina | 27710 | United States | Details |
| Baylor St Lukes | RECRUITING | Houston | Texas | 77030 | United States | Details |